Last week, the ABA Journal began work on its 5th annual list of the 100 best legal blogs (or blawgs) and announced that it is seeking the advice of its readers, via the ABAJournal.com website, on which blawgs and practice areas to include on this year's Blawg 100. Readers interested in nominating a particular blog or practice area should use the blawg 100 amici form provided on the ABA Journal website. Additional information about the Blawg 100 can also be found on the blawg 100 amici form. The form requires that anyone making a nomination provide a name, employer or law school, city, and e-mail address. Nominations must be submitted no later than Friday, September 9.
Contributors
Juristat #4 Overall Rank
Contact the Docs
Foreign Correspondents
Docs on Twitter
Recent Posts
- AbbVie Files Amicus Brief in Amgen v. Sanofi
- GlaxoSmithKline Files Amicus Brief in Amgen v. Sanofi
- Webinar on Priority Entitlement in Europe
- Webinar on Obtaining and Managing REMS Patent
- Patent Law Academics File Amicus Brief in Amgen v. Sanofi
- Amgen Files Reply Brief in Amgen v. Sanofi
- Conference & CLE Calendar
- Webinar on Prep, Prosecution & Profitability
- PIUG Webinar on Searching IP5 Literature
- Webinar on Unified Patent Court
Disclaimer
- "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank
- Powered By Invesp
« Court Report | Main | Legislators Urge President to Include 12-Year Data Exclusivity Period in Free Trade Agreement »
August 15, 2011
The comments to this entry are closed.
March 2023
Categories
- Best Mode (2)
- Biosimilars (242)
- Biotech/Pharma Business (175)
- Biotech/Pharma News (274)
- Board of Patent Appeals and Interferences (12)
- Claim Construction (97)
- Conferences & CLE's (2944)
- Court Report (507)
- Damages (37)
- Definiteness (25)
- District Court (214)
- Double Patenting (30)
- Enablement (40)
- Federal Circuit (965)
- Food and Drug Administration (102)
- Hatch-Waxman (88)
- Inequitable Conduct (52)
- Infringement - Contributory or Induced (25)
- Infringement - Literal or DOE (88)
- Injunction (33)
- International IP (294)
- Inventorship (15)
- Licensing (129)
- Media Commentary (68)
- Miscellaneous (160)
- News from Abroad (102)
- Novelty (70)
- Obviousness (213)
- Patent Exhaustion (3)
- Patent Legislation (305)
- Patent Litigation (216)
- Patent Office Rules & Procedures (813)
- Patent Profiles (104)
- Patent Prosecution (98)
- Patent Prosecution - International (26)
- Patent Research (4)
- Patent Trial and Appeal Board (357)
- Patentable Subject Matter (633)
- Personalized Medicine (5)
- Post-Grant Proceedings (155)
- PTAB Report (9)
- Study/Report (6)
- Supreme Court (245)
- Tools (5)
- Trade Secrets (10)
- Utility (4)
- Venue (11)
- Written Description (84)
Patent Resources
Patent Search
- Patent Search
Patent Blogs & Sites
- 717 Madison Place
- America-Israel Patent Law
- Anticipate This!
- BlawgIT
- Chicago IP Litigation Blog
- FedCircuitBlog
- Global Patent Quality
- Innovation Alliance
- Intellectual Property Watch
- IP Dragon
- IPcopy
- McCabe Ali LLP
- IPWatchdog.com
- Life Science IP
- Orange Book Blog
- Patent Blurb
- Patently-O
- Patentology
- Patents4Life
- Reexamination Center
- Intellepedia – IP News Center
- SPICY IP
Comments